Publications

  1. Lim JY, Deo SV, Jung SH, Altarabsheh SE, Erwin PJ, Dillon JJ, Park SJ. Does Off-pump Coronary Artery Bypass Confer any Advantage in Patients with End-stage Renal Failure? A Systematic Review and Meta-analysis. Heart Lung Circ. 2015 Jan; 24(1):55-61. Epub 2014 Jun 27.
    View PubMed
  2. Dillon JJ, DeSimone CV, Sapir Y, Somers VK, Dugan JL, Bruce CJ, Ackerman MJ, Asirvatham SJ, Striemer BL, Bukartyk J, Scott CG, Bennet KE, Mikell SB, Ladewig DJ, Gilles EJ, Geva A, Sadot D, Friedman PA. Noninvasive potassium determination using a mathematically processed ECG: Proof of concept for a novel "blood-less, blood test". J Electrocardiol. 2014 Oct 18.
    View PubMed
  3. Patel K, Dillon JJ, Leung N, Bomback AS, Appel GB, D'Agati V, Canetta PA. Use of bortezomib in heavy-chain deposition disease: a report of 3 cases. Am J Kidney Dis. 2014 Jul; 64(1):123-7. Epub 2014 Mar 05.
    View PubMed
  4. Deo SV, Sharma V, Altarabsheh SE, Hasin T, Dillon J, Shah IK, Durham LA 3rd, Stulak JM, Daly RC, Joyce LD, Park SJ. Hepatic and renal function with successful long-term support on a continuous flow left ventricular assist device. Heart Lung Circ. 2014 Mar; 23(3):229-33. Epub 2013 Aug 29.
    View PubMed
  5. Deo SV, Shah IK, Dunlay SM, Lim JY, Erwin PJ, Dillon JJ, Park SJ. Coronary artery bypass grafting versus drug-eluting stents in patients with end-stage renal disease. J Card Surg. 2014 Mar; 29(2):163-9.
  6. McCarthy JT, Hocum CL, Albright RC, Rogers J, Gallaher EJ, Steensma DP, Gudgell SF, Bergstralh EJ, Dillon JC, Hickson LJ, Williams AW, Dingli D. Biomedical system dynamics to improve anemia control with darbepoetin alfa in long-term hemodialysis patients. Mayo Clin Proc. 2014 Jan; 89(1):87-94.
    View PubMed
  7. Schoonover KL, Hickson LJ, Norby SM, Hogan MC, Chaudhary S, Albright RC Jr, Dillon JJ, McCarthy JT, Williams AW. Risk factors for hospitalization among older, incident haemodialysis patients. Nephrology (Carlton). 2013 Nov; 18(11):712-7.
    View PubMed
  8. Tumlin JA, Chawla L, Tolwani AJ, Mehta R, Dillon J, Finkel KW, DaSilva JR, Astor BC, Yevzlin AS, Humes HD. The effect of the selective cytopheretic device on acute kidney injury outcomes in the intensive care unit: a multicenter pilot study. Semin Dial. 2013 Sep-Oct; 26(5):616-23. Epub 2012 Oct 29.
    View PubMed
  9. Irazabal MV, Eirin A, Lieske J, Beck LH, Sethi S, Borland TM, Dillon JJ, Nachman PH, Nasr SH, Cornell LD, Leung N, Cattran DC, Fervenza FC. Low- and high-molecular-weight urinary proteins as predictors of response to rituximab in patients with membranous nephropathy: a prospective study. Nephrol Dial Transplant. 2013 Jan; 28(1):137-46. Epub 2012 Sep 17.
    View PubMed
  10. Dillon JJ, Hladunewich M, Haley WE, Reich HN, Cattran DC, Fervenza FC. Rituximab therapy for Type I membranoproliferative glomerulonephritis. Clin Nephrol. 2012 Apr; 77(4):290-5.
    View PubMed
  11. Schinstock CA, Albright RC, Williams AW, Dillon JJ, Bergstralh EJ, Jenson BM, McCarthy JT, Nath KA. Outcomes of arteriovenous fistula creation after the Fistula First Initiative. Clin J Am Soc Nephrol. 2011 Aug; 6(8):1996-2002. Epub 2011 Jul 07.
    View PubMed
  12. Fervenza FC, Abraham RS, Erickson SB, Irazabal MV, Eirin A, Specks U, Nachman PH, Bergstralh EJ, Leung N, Cosio FG, Hogan MC, Dillon JJ, Hickson LJ, Li X, Cattran DC, Mayo Nephrology Collaborative Group. Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol. 2010 Dec; 5(12):2188-98. Epub 2010 Aug 12.
    View PubMed
  13. Lorenz EC, Vrtiska TJ, Lieske JC, Dillon JJ, Stegall MD, Li X, Bergstralh EJ, Rule AD. Prevalence of renal artery and kidney abnormalities by computed tomography among healthy adults. Clin J Am Soc Nephrol. 2010 Mar; 5(3):431-8. Epub 2010 Jan 14.
    View PubMed
  14. Lieske JC, Regnier C, Dillon JJ. Use of sevelamer hydrochloride as an oxalate binder. J Urol. 2008 Apr; 179(4):1407-10. Epub 2008 Mar 04.
    View PubMed
  15. Boseman P, Lewin M, Dillon J, Sethi S. Marfan syndrome, MPGN, and bacterial endocarditis. Am J Kidney Dis. 2008 Apr; 51(4):697-701. Epub 2008 Mar 03.
    View PubMed
  16. Fervenza FC, Cosio FG, Erickson SB, Specks U, Herzenberg AM, Dillon JJ, Leung N, Cohen IM, Wochos DN, Bergstralh E, Hladunewich M, Cattran DC. Rituximab treatment of idiopathic membranous nephropathy. Kidney Int. 2008 Jan; 73(1):117-25. Epub 2007 Oct 17.
    View PubMed
  17. Dillon JJ. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy. Semin Nephrol. 2004 May; 24(3):218-24.
    View PubMed
  18. Hartman AR, Fleming GF, Dillon JJ. Meta-analysis of adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy in postmenopausal women with estrogen receptor-positive, node-positive breast cancer. Clin Breast Cancer. 2001 Jul; 2(2):138-43; discussion 144.
    View PubMed
  19. Dillon JJ. Nephrotoxicity from nonsteroidal anti-inflammatory drugs. MDVista Journalof Medicine Sept. 2000.
  20. Dillon JJ, IgA Nephropathy. IgA Nephropathy. . MDVista Journal of Medicine. 2000 Dec.
  21. Arnow PM, Garcia-Houchins S, Neagle MB, Bova JL, Dillon JJ, Chou T. An outbreak of bloodstream infections arising from hemodialysis equipment. J Infect Dis. 1998 Sep; 178(3):783-91.
    View PubMed
  22. Hartman AR, Williams SF, Dillon JJ. Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan/cyclophosphamide vs total body irradiation: a meta-analysis. Bone Marrow Transplant. 1998 Sep; 22(5):439-43.
    View PubMed
  23. Newell KA, Millis JM, Bruce DS, Woodle ES, Cronin DC, Loss G, Grewal H, Alonso EM, Dillon JJ, Whitington PF, Thistlethwaite JR Jr. An analysis of hepatic retransplantation in children. Transplantation. 1998 May 15; 65(9):1172-8.
    View PubMed
  24. Dillon JJ, Sedmak DD, Cosio FG. Rapid-onset diabetic nephropathy in type II diabetes mellitus. Ren Fail. 1997 Nov; 19(6):819-22.
    View PubMed
  25. Dillon JJ. Fish oil therapy for IgA nephropathy: efficacy and interstudy variability. J Am Soc Nephrol. 1997 Nov; 8(11):1739-44.
    View PubMed
  26. Hebert LA, Birmingham DJ, Mahan JD, Cosio FG, Dillon JJ, Sedmak DD, Shen XP, McAllister C. Effect of enalapril therapy on glomerular accumulation of immune complexes and mesangial matrix in experimental glomerulonephritis in the nonhuman primate. Am J Kidney Dis. 1997 Aug; 30(2):243-52.
    View PubMed
  27. Birmingham DJ, Shen XP, Hartman JA, Dillon JJ, Hebert LA. Effect of chronic human recombinant erythropoietin therapy on antibody responses to immunization in chronic hemodialysis patients. Kidney Int. 1996 Aug; 50(2):543-9.
    View PubMed
  28. Hebert LA, Dillon JJ, Middendorf DF, Lewis EJ, Peter JB. Relationship between appearance of urinary red blood cell/white blood cell casts and the onset of renal relapse in systemic lupus erythematosus. Am J Kidney Dis. 1995 Sep; 26(3):432-8.
    View PubMed
  29. Cosio FG, Dillon JJ, Falkenhain ME, Tesi RJ, Henry ML, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM. Racial differences in renal allograft survival: the role of systemic hypertension. Kidney Int. 1995 Apr; 47(4):1136-41.
    View PubMed
  30. Hebert LA, Birmingham DJ, Shen XP, Brandt JT, Sedmak DD, Dillon JJ. Effect of recombinant erythropoietin therapy on autoimmunity in systemic lupus erythematosus. Am J Kidney Dis. 1994 Jul; 24(1):25-32.
    View PubMed
  31. Hebert LA, Birmingham DJ, Dillon JJ, Cosio FG, Shen XP. Erythropoietin therapy in humans increases erythrocyte expression of complement receptor type 1 (CD35). J Am Soc Nephrol. 1994 Apr; 4(10):1786-91.
    View PubMed
  32. Hebert LA, Birmingham DJ, Mahan JD, Shen XP, McAllister C, Cosio FG, Dillon JJ. Effect of chronically increased erythrocyte complement receptors on immune complex nephritis. Kidney Int. 1994 Feb; 45(2):493-9.
    View PubMed
  33. Dillon JJ. The quantitative relationship between treated blood pressure and progression of diabetic renal disease. Am J Kidney Dis. 1993 Dec; 22(6):798-802.
    View PubMed
  34. Dillon JJ, Grossman SH, Finn WF. Effect of oxypurinol on renal reperfusion injury in the rat. Ren Fail. 1993; 15(1):37-45.
    View PubMed
  35. McCormack AJ, Snipes RG, Dillon JJ, Yang JJ, Finn WF. Primary renovascular effects of erythromycin in the rat: relationship to cyclosporine nephrotoxicity. Ren Fail. 1990; 12(4):241-8.
    View PubMed
  36. Dillon JJ, Finn WF. How can the high mortality of acute renal failure be reduced? Semin Dial. 1988; 1:133-5.